Treatment outcomes of patients with stage III non-small cell lung cancer and interstitial lung diseases receiving intensity-modulated radiation therapy: A single-center experience of 85 cases.
Linfang WuShijun ZhaoHui HuangWenqing WangTao ZhangZongmei ZhouQin-Fu FengJun LiangZefen XiaoZhouguang HuiJima LvNan BiLuhua WangPublished in: Thoracic cancer (2022)
Honeycombing score >1 and V20 ≥20% were associated with high incidence of RILTs. However, patients with low risk might benefit from IMRT with acceptable toxicities and durable OS.